Albarran V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Roman M, Calvo JC, Perez de Aguado P, Moreno J, Guerrero P, Gonzalez C, Garcia de Quevedo C, Alvarez-Ballesteros P, Vaz MA (2022) Receptor tyrosine kinase inhibitors for the treatment of recurrent and unresectable bone sarcomas. Int J Mol Sci 23(22):13784
Article CAS PubMed PubMed Central Google Scholar
Blum A, Wang P, Zenklusen JC (2018) SnapShot: TCGA-analyzed tumors. Cell 173(2):530
Article CAS PubMed Google Scholar
Caiazza C, Brusco T, D’Alessio F, D’Agostino M, Avagliano A, Arcucci A, Ambrosino C, Fiume G, Mallardo M (2022) The lack of STING impairs the MHC-I dependent antigen presentation and JAK/STAT signaling in murine macrophages. Int J Mol Sci 23(22):14232
Article CAS PubMed PubMed Central Google Scholar
Cheng R, Santos HA (2023) Smart Nanoparticle-Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy. Adv Healthc Mater 12(8)
Das S, Faruqi S, Nordal R, Starreveld Y, Kelly J, Bowden G, Amanie J, Fairchild A, Lim G, Loewen S, Rowe L, Wallace C, Ghosh S, Patel S (2022) A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases. BMC Cancer 22(1):1368
Article PubMed PubMed Central Google Scholar
Jenkins BD, Martini RN, Hire R, Brown A, Bennett B, Brown I, Howerth EW, Egan M, Hodgson J, Yates C, Kittles R, Chitale D, Ali H, Nathanson D, Nikolinakos P, Newman L, Monteil M, Davis MB (2019) Atypical chemokine receptor 1 (DARC/ACKR1) in breast tumors is associated with survival, circulating chemokines, tumor-infiltrating immune cells, and African ancestry. Cancer Epidemiol Biomarkers Prev 28(4):690–700
Article CAS PubMed PubMed Central Google Scholar
Jinna N, Rida P, Su T, Gong Z, Yao S, LaBarge M, Natarajan R, Jovanovic-Talisman T, Ambrosone C, Seewaldt V (2022) The DARC side of inflamm-aging: duffy antigen receptor for chemokines (DARC/ACKR1) as a potential biomarker of aging, immunosenescence, and breast oncogenesis among high-risk subpopulations. Cells 11(23):3818
Article CAS PubMed PubMed Central Google Scholar
Karthik N, Lee JJH, Soon JLJ, Chiu HY, Loh AHP, Ong DST, Tam WL, Taneja R (2022) Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma. J Pathol 259(3):342–356
Larrier NA, Kirsch DG, Riedel RF, Levinson H, Eward WC, Brigman BE (2013a) Practical radiation oncology for extremity sarcomas. Surg Oncol Clin N Am 22(3):433–443
Larrier NA, Kirsch DG, Riedel RF, Levinson H, Eward WC, Brigman BE (2013b) Practical radiation oncology for extremity sarcomas. Surg Oncol Clin N Am 22(3):433–443
Latini FR, Bastos AU, Arnoni CP, Muniz JG, Person RM, Baleotti W Jr, Barreto JA, Castilho L, Cerutti JM (2013) DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer. Blood Cells Mol Dis 50(3):161–165
Article CAS PubMed Google Scholar
Lee JS, Frevert CW, Wurfel MM, Peiper SC, Wong VA, Ballman KK, Ruzinski JT, Rhim JS, Martin TR, Goodman RB (2003) Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 170(10):5244–5251
Article CAS PubMed Google Scholar
Li Y, Hu X, Lin R, Zhou G, Zhao L, Zhao D, Zhang Y, Li W, Zhang Y, Ma P, Ren H, Liao X, Niu P, Wang T, Zhang X, Wang W, Gao R, Li Q, Church G et al (2022a) Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer. Theranostics 12(8):3818–3833
Article CAS PubMed PubMed Central Google Scholar
Li Z, Wang M, Tan J, Zhu L, Zeng P, Chen X, Xie L, Duan R, Chen B, Tao T, Wang R, Wang X, Su W (2022b) Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med 3(8):100699
Article CAS PubMed PubMed Central Google Scholar
Lv M, He F, Guo J, Zheng Z, Wang W, Xie J (2022) Identification of hub genes correlated with tumor-associated M1-like macrophage infiltration in soft tissue sarcomas. Front Genet 13:999966
Article CAS PubMed PubMed Central Google Scholar
Maeda S, Kuboki S, Nojima H, Shimizu H, Yoshitomi H, Furukawa K, Miyazaki M, Ohtsuka M (2017) Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma. Cytokine 95:12–21
Article CAS PubMed Google Scholar
Nicolo E, Giugliano F, Ascione L, Tarantino P, Corti C, Tolaney SM, Cristofanilli M, Curigliano G (2022) Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives. Cancer Treat Rev 106:102395
Article CAS PubMed Google Scholar
Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, Chu KC, Wong CY, Lau CY, Chen I, Chan NW, Zhang J (2019) TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35(20):4200–4202
Article CAS PubMed Google Scholar
Rushdi MN, Pan V, Li K, Choi HK, Travaglino S, Hong J, Griffitts F, Agnihotri P, Mariuzza RA, Ke Y, Zhu C (2022) Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity. Nat Commun 13(1):7055
Article CAS PubMed PubMed Central Google Scholar
Salguero-Aranda C, Olmedo-Pelayo J, de Alava E, Amaral AT, Diaz-Martin J (2022) Genetic alterations and deregulation of hippo pathway as a pathogenetic mechanism in bone and soft tissue sarcoma. Cancers (Basel) 14(24):6211
Article CAS PubMed Google Scholar
Smith KB, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Kirwan JM, Zlotecki RA, Scarborough MT, Gibbs CP, Marcus RB (2011) Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 81(1):150–157
Sun G, Wang Y, Zhu Y, Huang C, Ji Q (2011) Duffy antigen receptor for chemokines in laryngeal squamous cell carcinoma as a negative regulator. Acta Otolaryngol 131(2):197–203
Article CAS PubMed Google Scholar
Tang F, Tie Y, Wei YQ, Tu CQ, Wei XW (2021) Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Biochim Biophys Acta Rev Cancer 1876(2):188606
Article CAS PubMed Google Scholar
Thirasastr P, Brahmi M, Dufresne A, Somaiah N, Blay JY (2022) New drug approvals for sarcoma in the last 5 years. Surg Oncol Clin N Am 31(3):361–380
Tian Z, Yao W (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Front Pharmacol 14:1199292
Article CAS PubMed PubMed Central Google Scholar
Tong Y, Pi Y, Cui Y, Jiang L, Gong Y, Zhao D (2022) Early distinction of lymph node metastasis in patients with soft tissue sarcoma and individualized survival prediction using the online available nomograms: a population-based analysis. Front Oncol 12:959804
Article PubMed PubMed Central Google Scholar
Yang J, Xu Y, Chen Y, Li T, Zhang X, Hu T, Xing R, Yang Y (2022a) Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. Cancer Biol Med 19(10):1496–1502
Article CAS PubMed PubMed Central Google Scholar
Yang Y, Ye F, Xia T, Wang Q, Du J (2022b) High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. BMC Cancer 22(1):1355
Article CAS PubMed PubMed Central Google Scholar
Yin Q, Srivastava K, Gebremedhin A, Makuria AT, Flegel WA (2018) Long-range haplotype analysis of the malaria parasite receptor gene ACKR1 in an East-African population. Hum Genome Var 5:26
Article PubMed PubMed Central Google Scholar
Zhu Q, Jiang L, Wang X (2017) The expression of Duffy antigen receptor for chemokines by epithelial ovarian cancer decreases growth potential. Oncol Lett 13(6):4302–4306
Article CAS PubMed PubMed Central Google Scholar
Zou MZ, Liu WL, Chen HS, Bai XF, Gao F, Ye JJ, Cheng H, Zhang XZ (2021) Advances in nanomaterials for treatment of hypoxic tumor. Natl Sci Rev 8(2):nwaa160
Comments (0)